Clinical Trials Browser

Withdrawn × Colorectal Neoplasms × Interleukin-2 × Clear all

NCT03222089 2018-03-27

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms